Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
about
Therapies targeting cancer stem cells: Current trends and future challengesThe Tumor Macroenvironment: Cancer-Promoting Networks Beyond Tumor BedsA meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancerA multi-targeted approach to suppress tumor-promoting inflammationThe N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanismClinicopathological significance of CXCR4 in non-small cell lung cancer.Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.Downregulation of CXCR4 Expression and Functionality After Zoledronate Exposure in Canine OsteosarcomaOvercoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors.Expression array analysis of the hepatocyte growth factor invasive program.CXCR4 antagonists suppress small cell lung cancer progression.Chronic lymphocytic leukemia cells are active participants in microenvironmental cross-talk.Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.Targeting Macrophages in Cancer: From Bench to Bedside.CXCR4-directed theranostics in oncology and inflammation
P2860
Q26777880-47E4821E-70A4-42B9-852A-B0664F4D31DAQ26799120-66B82E65-54A2-46AF-9CA1-C37571B38BBBQ26998677-AE3D7D90-C222-4F15-B77F-7303461213E4Q28393278-F9010262-4FED-4CC9-8FDA-A5421E0DF562Q33913982-1F9A5DCF-6835-4B07-847A-57FE0D42C0FCQ35171366-3145E92D-F60C-427A-A308-3C6A8AAD86EDQ35550241-E2164795-03F8-42F8-9678-D3459C7225E3Q36413901-7B37E324-146E-4B5D-9E0E-1111F0B24EC4Q37384979-686833C2-0471-429C-A3D0-7B4CA708C0E1Q37690136-00B58453-CCFA-4989-BD65-00980669036AQ38847534-72B845A4-5ACF-4F57-B84E-B1F1B6FCC9E9Q42089559-E1415087-813C-4C35-A100-E27C6C692A64Q46011813-ADAD85BE-45F4-41E4-8F83-D8E679B87545Q47850217-CE0B55FF-19DD-46D4-9BB8-EAA28EBA5454Q52936904-5EB77433-84A4-4F31-8245-3A1D3A52AB2CQ55315292-22AF9ABE-082A-4BE2-BB31-352A7AB55CBAQ58783862-B97B2BA5-C078-4BD2-8C4D-E4C904FCED48
P2860
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
@en
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
@nl
type
label
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
@en
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
@nl
prefLabel
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
@en
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
@nl
P2093
P2860
P356
P1433
P1476
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis.
@en
P2093
Donald Wong
Pridvi Kandagatla
Sreenivasa R Chinni
Walter Korz
P2860
P2888
P356
10.1186/1471-2490-14-12
P577
2014-01-28T00:00:00Z
P5875
P6179
1024285676